PLSE
HEALTHCAREPulse Biosciences Inc
$19.21+0.56 (+3.00%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving PLSE Today?
No stock-specific AI insight has been generated for PLSE yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$12.56$26.30
$19.21
Fundamentals
Market Cap$1.3B
P/E Ratio—
EPS$-1.10
Dividend Yield—
Dividend / Share—
ROE-0.8%
Profit Margin—
Debt / Equity—
Trading
Volume236K
Avg Volume (10D)—
Shares Outstanding68.2M
PLSE News
21 articles- Pulse Biosciences Q1 Earnings Call HighlightsMarketbeat·May 8, 2026
- PLSE Q1 2026 Earnings TranscriptMotley Fool·May 8, 2026
- Pulse Biosciences to Present at the BofA Securities 2026 Healthcare ConferenceYahoo Finance·May 8, 2026
- Pulse Biosciences (PLSE) Upgraded to Buy: What Does It Mean for the Stock?Yahoo Finance·May 7, 2026
- Turbett Surgical Appoints Kevin Danahy as President and Chief Executive Officer to Lead Growth PhaseYahoo Finance·May 6, 2026
- Pulse Biosciences (PLSE) Q1 2025 Earnings TranscriptThe Motley Fool·May 4, 2026
- PLSE Q4 2025 Earnings TranscriptMotley Fool·May 4, 2026
- Pulse Biosciences, Inc (PLSE) Reports Q1 Loss, Lags Revenue EstimatesYahoo Finance·May 4, 2026
- Pulse Biosciences Reports Business Updates and First Quarter 2026 Financial ResultsYahoo Finance·May 4, 2026
- Pulse Biosciences Presents Positive Outcomes in Late-Breaking Updated Data from nPulse™ Cardiac Catheter System at Heart Rhythm 2026Yahoo Finance·Apr 25, 2026
- Pulse Biosciences Trials And Conference Spotlight Reframe Pulse Field Ablation StoryYahoo Finance·Apr 23, 2026
- Pulse Biosciences (PLSE) Enrolls Its First Patients in a Pivotal Atrial Fibrillation TrialYahoo Finance·Apr 20, 2026
- Pulse Biosciences’ nPulse™ Technology to be Featured at the Heart Rhythm Society 2026 Annual MeetingYahoo Finance·Apr 20, 2026
- Pulse Biosciences to Host Analyst Event on April 25, 2026Yahoo Finance·Apr 17, 2026
- Pulse Biosciences Initiates Patient Enrollment in NANOPULSE-AF StudyYahoo Finance·Apr 13, 2026
- Can Pulse Biosciences’ (PLSE) New AF Study and C-Suite Hires Reframe Its PFA Strategy?Yahoo Finance·Apr 12, 2026
- Pulse Biosciences hires Liane Teplitsky as COOMedtechdive·Apr 10, 2026
- Pulse Biosciences Strengthens Executive Leadership TeamYahoo Finance·Apr 9, 2026
- Pulse Biosciences Enrolls First Patients in NANOPULSE-AF IDE Pivotal Clinical Study Evaluating nPulse™ Cardiac Catheter System for Atrial FibrillationYahoo Finance·Apr 7, 2026
- Pulse Biosciences to Present at the 25th Annual Needham Virtual Healthcare ConferenceYahoo Finance·Apr 2, 2026
- PLSE Accelerates Cardiac Catheter Program After Breakthrough AFib DataYahoo Finance·Mar 26, 2026
All 21 articles loaded
Price Data
Open$18.49
Previous Close$18.65
Day High$19.40
Day Low$18.36
52 Week High$26.30
52 Week Low$12.56
52-Week Range
$12.56$26.30
$19.21
Fundamentals
Market Cap$1.3B
P/E Ratio—
EPS$-1.10
Dividend Yield—
Dividend / Share—
ROE-0.8%
Profit Margin—
Debt / Equity—
Trading
Volume236K
Avg Volume (10D)—
Shares Outstanding68.2M
About Pulse Biosciences Inc
Pulse Biosciences, Inc. is a bioelectrical medicine startup. The company is headquartered in Hayward, California.
HEALTHCAREMEDICAL INSTRUMENTS & SUPPLIES
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICMEDICAL INSTRUMENTS & SUPPLIES
CIK—
Composite FIGI—
Share Class FIGI—